Fidelity Investments’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Fidelity Investments’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-81,740	Closed	-$1M	–	5640
2022 Q4	$1M	Sell	81,740 -103,092	-56%	-$2.46M	﹤0.01%	2542
2022 Q3	$6.07M	Buy	184,832 +99,598	+117%	+$2.81M	﹤0.01%	2101
2022 Q2	$1.61M	Buy	85,234 +3,065	+4%	+$58.7K	﹤0.01%	2560
2022 Q1	$1.44M	Buy	+82,169	New	+$1.69M	﹤0.01%	2693

Fidelity Investments's CINC Position: Q1 2023 in Review

Fidelity Investments sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 81,740 shares — an estimated $1M sold.

Fidelity Investments first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $6.07M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Fidelity Investments reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Fidelity Investments sold 81,740 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1M.
Fidelity Investments first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Fidelity Investments's CinCor Pharma, Inc. Common Stock position peaked at $6.07M in Q3 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.